• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Maximum body mass index over 24-year weight history linked to increased all-cause mortality

byJames EnglandandAnees Daud
November 19, 2018
in Chronic Disease, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this prospective study of the original and offspring Framingham cohort, maximum body mass index (BMI) over the course of a 24-year weight history was associated with increased risk of all-cause mortality. Greater levels of obesity were linked with higher-risk of mortality.

2. Individuals who were previously overweight or obese but were normal weight at time of baseline assessment were observed to have a higher mortality rate than those who were never overweight.

Evidence Rating Level: 2 (Good)           

Study Rundown: Obesity is a well-established risk factor for cardiovascular and metabolic diseases, however prior meta-analyses have found a paradoxical reduced mortality in people who are overweight. Many of these prior studies have been criticized for being subject to reverse causality bias where weight at the baseline assessment may reflect systemic conditions that affect weight status and mortality. The current study sought to evaluate the impact of maximum BMI evaluated over a prolonged weight history period on all-cause mortality in order to minimize reverse causality bias. Using data from the original and offspring Framingham cohort studies, a 24-year weight history was obtained prior to analysis of mortality. The study found that maximum BMI was linked to increased mortality, with greater obesity conferring a higher risk. The study also found increased mortality amongst those who were normal weight but previously overweight or obese compared to those that were always normal weight.

The main strengths of the study include its long follow-up periods and repeated weight measurements over a prolonged weight history period. The main limitations to this study include the limited numbers of low-weight participants, and homogenous population of Caucasian participants hindering generalizability.

Click to read the study published in JAMA Network Open

RELATED REPORTS

Significant body weight reduction with cagrilintide-semaglutide therapy

#VisualAbstract: Once-weekly Semaglutide Reduces Body Weight in People with Obesity

Tirzepatide leads to greater weight loss than semaglutide among adults with obesity

Relevant Reading: Weight Histories and Mortality Among Finnish Adults: The Role of Duration and Peak Body Mass Index

In-Depth [prospective cohort]: This study is a prospective cohort study including the Framingham Heart Study and its offspring cohort. The baseline examination marked the beginning of survival analysis and included 24 years of weight history. Participants who died or were lost to follow-up prior to the baseline examination were excluded, as were those bellow 20-years of age at enrollment, had fewer than 3 weight records, or who were underweight.

A total of 6197 participants were included in the study, with a mean follow-up of 17 years from the baseline examination and 3478 total deaths during the study period. Using the maximum BMI over the weight record period, 77% of participants were classified as overweight or obese. Those who were overweight did not demonstrate increased mortality (BMI of 25 to <30; hazard ratio [HR], 1.08; 95%CI, 0.99-1.18), but those who were BMI of 30 to <35 (HR 1.27; 95%CI, 1.14-1.41) and BMI of 35 to <40 (HR, 1.93; 95%CI, 1.68-2.20) did have an increased mortality. Those who were normal weight at baseline but previously overweight (47.48 per 1000 person-years), or obese (66.67 per 1000 person-years) had higher mortality rates than those that were always normal weight (27.93 per 1000 person-years)

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: obesity
Previous Post

Marijuana exposure common in children of tobacco smokers

Next Post

Diabetes patients with high-deductible health care plans may delay seeking crucial care

RelatedReports

Cardiology

Significant body weight reduction with cagrilintide-semaglutide therapy

August 29, 2025
#VisualAbstract: Once-weekly Semaglutide Reduces Body Weight in People with Obesity
StudyGraphics

#VisualAbstract: Once-weekly Semaglutide Reduces Body Weight in People with Obesity

August 27, 2025
Parental conceptions of weight are becoming increasingly inaccurate
Cardiology

Tirzepatide leads to greater weight loss than semaglutide among adults with obesity

August 26, 2025
Tramadol use linked with increased risk of hypoglycemia hospitalizations
Pharma

Lilly Strikes $1.3 Billion GPCR Drug Discovery Pact with Superluminal

August 20, 2025
Next Post

Diabetes patients with high-deductible health care plans may delay seeking crucial care

Prevalence of hypertension among adolescents varies by race and BMI

Nurse Practitioners and Physician Assistants can effectively manage chronic conditions, fill gaps in primary care

Patient-reported outcomes differ significantly based on treatment in prostate cancer: The ProtecT trial

2 Minute Medicine Rewind November 19, 2018

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study
  • An absence of cardiovascular risk factors is linked to over ten additional healthy years
  • Association between serum albumin to creatinine ratio and non-alcoholic fatty liver disease: a longitudinal cohort study in non-obese Chinese individuals
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.